ª÷¿ÄªÑ¤U·Æ ¼Ð«ü®À1.33%
¡i©ú³ø±M°T¡j¹Dã´µ¤u·~«ü¼Æ©P¤G³s³Ð²Ä¥|·s°ª¬ö¿ý¡A¼Ð·Ç´¶º¸500²¤°¡A¨ü²Ö©óºô¤W®È¹C¤½¥qPriceline¬Õ§Q¹w´ú¥O¤H¥¢±æ¡Aª÷¿ÄªÑ¤U·Æ¡C¼Ð´¶500ª÷¿Ä«ü¼Æ´î1.33%¡A¬O¥Dn¤U¦æ©Ô¤O¡C
¤½¥Î¨Æ·~¤Î°ò¥»®ø¶O«~¦b¼Ð´¶500¤É´T³Ì¤j¡A¨âªÌ¨ú±o1%¥H¤Wº¦´T¡AÄ_ÆP(Procter & Gamble)¤É1.08%¡C
°ª²±(Goldman Sachs)·l1.51%¡A³Ì¤jªº©Ô¸¨¹Dã´µ¡A¼Ð´¶500«ü¼Æ¤T¤j
©ì²Ö¦]¯À¥]¬AJPMorgan»P¬ü°ê»È¦æ¡C
ºô¤W®È¹C¥¨À¼¬Õ§Q¹w´ú¥¢¦å¡A§ë¸ê¤H¥çµJļ¤£¦w¡A¦@©MÄÒ¬Fµ¦«d´î¥ø·~µ|¥i¯à¹pÁn¤j«BÁn¤p¡C
ºô¤W®È¹C¥¨À¼Priceline¤U·Æ13.52%¡AÄvª§¹ï¤âTripAdvisor¼@´î23.22%¡A5¦~³Ì§Cªí²{¡A¦«e¨â®a¤½¥q©u«×¬Õ§Q¹w´ú¥O¤H¥¢±æ¡C
§ë¸ê¤H¥çºò±i¡A¾á¤ß¦@©MÄÒ´îµ|p¹º³Ì²×®ø®§¡A¤W©P«Å¥¬¡A±N¥ø·~µ|±q35%°¦Ü20%¡A¦ýªk®×¨ú®ø³\¦hµ|°ÈÀu´f¡A®Æ±N¾D¹J§Q¯q¹ÎÅé¤Ï¹ï¡C
¦hÛ¦hÃÒ¨é¥æ©ö©Ò¼Ð´¶TSXºî¦X«ü¼Æ²r¤É39.59ÂI¡A¦Ü16,131.79ÂI¡A¨ì¹F¬ö¿ý·s°ª¡A±a¤É¥D¤O¬°»í¥_§J¤Z§Q¨È»sÃÄ°ê»Ú¶°¹Î(Valeant Pharmaceuticals International)¡A¦¬³øº¦¹O17%¡C
«ü¼Æ10¤j²£·~ªº¨ä¤¤6¶µ§¡§iº¦¤É¡A¤Z§Q¨È»sÃĦ¥«¤w¤É16.3%¡A¦Ü¨CªÑ17.95¤¸¡A³ø§iªº©u«×¬Õ§QÀu©ó¹w´ú¡A¨ü¯q©óBausch»PLomb²´²´·úÅ@²z·~°È¡CÂåÀøÅ@²zªÑ®Ê¤É3.9%¡C
µØº¸µó¹Dã´µ¤u·~¥§¡¤É8.81ÂI¡A¦Ü23,557.23ÂI¡C¼Ð´¶500¥¢0.49ÂI¡A¦Ü2,590.64ÂI¡C¯Ç´µ¹F§Jºî¦X«ü¼Æ¤U·Æ18.65ÂI¡A¦Ü6,767.78ÂI¡C